$63.85+27.62% · 3M
Moving avg
1W+7.90%
1M-6.49%
3M+30.19%
6M+51.19%
YTD+106.89%
1Y+139.21%
3Y-36.15%
5Y-82.92%
52-week range
$22.2866% of range$85.60
Company health
Value1/6
Growth3/6
Profitability1/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Revenue compounding 38% a year
- Net cash on the balance sheet
Risks
- Trades 28% above the average analyst target
- Currently unprofitable
- Burning free cash flow
Key statistics
Valuation
Market cap
$25.33B
Enterprise value
$21.46B
P/E ratio (TTM)
-6.83x
P/S ratio (TTM)
9.92x
EV/EBITDA
-7.44x
Per share & returns
EPS (TTM)
-$8.09
Dividend yield
0.00%
Beta (1Y)
0.94
30-day change
-6.49%
Trading
Volume (24h)
2.52M
Previous close
$63.67
Shares outstanding
396.79M
About Moderna, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
MRNA
Moderna, Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker MRNA.
Frequently asked questions
What is Moderna, Inc.'s market cap?
Moderna, Inc. (MRNA) has a market capitalization of $25.33B.
What sector is Moderna, Inc. in?
Moderna, Inc. operates in the Healthcare sector, Biotechnology industry.
What exchange does MRNA trade on?
MRNA trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,216.03-0.35%
$1.15T cap
Johnson & JohnsonJNJ
$261.33+0.18%
$629.78B cap
AbbVie Inc.ABBV
$250.78+0.81%
$443.08B cap
UnitedHealth Group IncorporatedUNH
$402.12-0.86%
$365.18B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.53+1.21%
$332.26B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap